268 related articles for article (PubMed ID: 33137621)
1. Multi-parametric MRI lesion heterogeneity biomarkers for breast cancer diagnosis.
Tsarouchi MI; Vlachopoulos GF; Karahaliou AN; Vassiou KG; Costaridou LI
Phys Med; 2020 Dec; 80():101-110. PubMed ID: 33137621
[TBL] [Abstract][Full Text] [Related]
2. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
4. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions.
Milenković J; Hertl K; Košir A; Zibert J; Tasič JF
Artif Intell Med; 2013 Jun; 58(2):101-14. PubMed ID: 23548472
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Classification on Multiparametric MRI - Increased Performance of Boosting Ensemble Methods.
Vamvakas A; Tsivaka D; Logothetis A; Vassiou K; Tsougos I
Technol Cancer Res Treat; 2022; 21():15330338221087828. PubMed ID: 35341421
[No Abstract] [Full Text] [Related]
6. Fully automatic classification of breast lesions on multi-parameter MRI using a radiomics model with minimal number of stable, interpretable features.
Zhang J; Zhan C; Zhang C; Song Y; Yan X; Guo Y; Ai T; Yang G
Radiol Med; 2023 Feb; 128(2):160-170. PubMed ID: 36670236
[TBL] [Abstract][Full Text] [Related]
7. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
[TBL] [Abstract][Full Text] [Related]
11. Automatic stratification of prostate tumour aggressiveness using multiparametric MRI: a horizontal comparison of texture features.
Sun Y; Reynolds HM; Wraith D; Williams S; Finnegan ME; Mitchell C; Murphy D; Haworth A
Acta Oncol; 2019 Aug; 58(8):1118-1126. PubMed ID: 30994052
[No Abstract] [Full Text] [Related]
12. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
[TBL] [Abstract][Full Text] [Related]
13. Automatic segmentation and classification of breast lesions through identification of informative multiparametric PET/MRI features.
Vogl WD; Pinker K; Helbich TH; Bickel H; Grabner G; Bogner W; Gruber S; Bago-Horvath Z; Dubsky P; Langs G
Eur Radiol Exp; 2019 Apr; 3(1):18. PubMed ID: 31030291
[TBL] [Abstract][Full Text] [Related]
14. Spectral embedding based active contour (SEAC) for lesion segmentation on breast dynamic contrast enhanced magnetic resonance imaging.
Agner SC; Xu J; Madabhushi A
Med Phys; 2013 Mar; 40(3):032305. PubMed ID: 23464337
[TBL] [Abstract][Full Text] [Related]
15. Textural analysis of early-phase spatiotemporal changes in contrast enhancement of breast lesions imaged with an ultrafast DCE-MRI protocol.
Milenković J; Dalmış MU; Žgajnar J; Platel B
Med Phys; 2017 Sep; 44(9):4652-4664. PubMed ID: 28622412
[TBL] [Abstract][Full Text] [Related]
16. Classification of pulmonary lesion based on multiparametric MRI: utility of radiomics and comparison of machine learning methods.
Wang X; Wan Q; Chen H; Li Y; Li X
Eur Radiol; 2020 Aug; 30(8):4595-4605. PubMed ID: 32222795
[TBL] [Abstract][Full Text] [Related]
17. Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis.
Karahaliou A; Vassiou K; Arikidis NS; Skiadopoulos S; Kanavou T; Costaridou L
Br J Radiol; 2010 Apr; 83(988):296-309. PubMed ID: 20335440
[TBL] [Abstract][Full Text] [Related]
18. Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging.
Zhang X; Xu X; Tian Q; Li B; Wu Y; Yang Z; Liang Z; Liu Y; Cui G; Lu H
J Magn Reson Imaging; 2017 Nov; 46(5):1281-1288. PubMed ID: 28199039
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2- Breast Cancer Quantified With 21-Gene Recurrence Score.
Chen Y; Tang W; Liu W; Li R; Wang Q; Shen X; Gong J; Gu Y; Peng W
J Magn Reson Imaging; 2023 Aug; 58(2):444-453. PubMed ID: 36440706
[TBL] [Abstract][Full Text] [Related]
20. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
